SLC1A2 and Alzheimer disease: Thus, developing a tool, such as PS1/GLT-1 CPP, to modulate the interaction between GLT-1 and PS1 in their native environment within cells is a crucial step for uncovering the significance of this interaction, providing therapeutic potential for AD.